Compare ALGS & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALGS | NNBR |
|---|---|---|
| Founded | 2018 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.2M | 63.7M |
| IPO Year | 2020 | 1994 |
| Metric | ALGS | NNBR |
|---|---|---|
| Price | $11.14 | $1.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $60.00 | N/A |
| AVG Volume (30 Days) | 81.5K | ★ 487.8K |
| Earning Date | 11-06-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,646,000.00 | ★ $424,005,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.76 | $1.10 |
| 52 Week High | $46.80 | $4.67 |
| Indicator | ALGS | NNBR |
|---|---|---|
| Relative Strength Index (RSI) | 60.44 | 38.02 |
| Support Level | $9.10 | $1.17 |
| Resistance Level | $13.69 | $1.45 |
| Average True Range (ATR) | 0.87 | 0.11 |
| MACD | 0.24 | 0.02 |
| Stochastic Oscillator | 50.23 | 30.05 |
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.